Latest Salix Pharmaceuticals Stories

2014-05-14 23:17:05

Specialty pharmaceutical leader continues to drive efforts to help support growth as revenues surpass $1 billion with recent acquisition REDWOOD SHORES, Calif.

2008-11-03 12:00:26

Salix Pharmaceuticals, a specialty pharmaceutical company, has announced that the FDA has granted marketing approval for Apriso extended-release capsules 0.375gm.

2008-07-01 06:00:49

Salix Pharmaceuticals has initiated patient enrollment in Target 1 and Target 2, its Phase III, randomized, double-blind, placebo-controlled, multicenter studies to assess the efficacy and safety of rifaximin 550mg, dosed three times daily, in the treatment of subjects with non-constipation irritable bowel syndrome.

Word of the Day
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.